BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer

Journal of Pathology

Volumn 221, Issue 2, 2010, Pages 229-237

  Nagji, Alykhan S ^a   Liu, Yuan ^a   Stelow, Edward B ^a   Stukenborg, George J ^b   Jones, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

BRMS1; Immunohistochemistry; Lung cancer; Methylation; Methylation specific PCR; Pathological stage; Squamous cell cancer

Indexed keywords

BISULFITE; BREAST CANCER METASTASIS SUPPRESSOR 1 PROTEIN; LUCIFERASE; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; METHYLATION; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CPG ISLANDS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METHYLATION; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 77952748211     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2707     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000; 60: 2764-2769.
3. Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J. Reduced metastasis-suppressor gene mRNA expression in breast cancer brain metastases. J Cancer Res Clin Oncol 2005; 131: 191-198. (Pubitemid 40175014)
4. Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin Cancer Res 2006; 12: 6410-6414. (Pubitemid 44799712)
5. Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity. Cancer Res 2005; 65: 3586-3595. (Pubitemid 40616334)
6. Liu Y, Smith PW, Jones DR. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 2006; 26: 8683-8696. (Pubitemid 44851930)
7. Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, et al . Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation. Mol Cancer 2007; 6: 6. (Pubitemid 46243445)
8. DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC, et al . Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res 2005; 65: 713-717. (Pubitemid 40216427)
9. Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, et al . Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metast 2000; 18: 683-693.
10. Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, et al . Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001; 61: 1765-1767. (Pubitemid 32691980)
11. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, et al . Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002; 273: 229-239. (Pubitemid 34920673)
12. Metge BJ, Frost AR, King JA, Dyess DL, Welch DR, Samant RS, et al . Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin Exp Metast 2008; 25: 753-763.
13. Illingworth RS, Bird AP. CpG islands - 'a rough guide'. FEBS Lett 2009; 583: 1713-1720.
14. Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 2009; 276: 196-203.
15. Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 2006; 281: 19700-19708. (Pubitemid 44035472)
16. McCullagh P, Nelder J. Generalized Linear Models, 2nd edn. Chapman and Hall/CRC: Boca Raton, FL, 1989.
17. Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, Feng R, et al . A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biol 2009; 30: 148-159.
18. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168-174.
19. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-692.
21. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2007; 2: 327-343. (Pubitemid 47181718)
22. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002; 21: 5450-5461.
23. Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 2001; 61: 3581-3585. (Pubitemid 32694965)
24. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61: 249-255. (Pubitemid 32095725)
25. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 2000; 92: 1717-1730.
26. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al . DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38: 1378-1385. (Pubitemid 44837559)
27. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 1992; 11: 327-333.
28. Hsieh CL. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994; 14: 5487-5494.
29. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics 1992; 13: 1095-1107.
30. Zhu J, He F, Hu S, Yu J. On the nature of human housekeeping genes. Trends Genet 2008; 24: 481-484.
31. Oakes CC, La Salle S, Smiraglia DJ, Robaire B, Trasler JM. A unique configuration of genome-wide DNA methylation patterns in the testis. Proc Natl Acad Sci USA 2007; 104: 228-233. (Pubitemid 46068014)
32. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al . DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358: 1118-1128. (Pubitemid 351398486)
33. Seifart C, Lin HM, Seifart U, Plagens A, DiAngelo S, von Wichert P, et al . Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma. Clin Genet 2005; 68: 128-136. (Pubitemid 40990623)
34. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG. High frequency of retinoic acid receptor-β abnormalities in human lung cancer. Oncogene 1991; 6: 1859-1868. (Pubitemid 21924019)
35. Geradts J, Chen JY, Russell EK, Yankaskas JR, Nieves L, Minna JD. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ 1993; 4: 799-809.
36. Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, et al . Suppression of retinoic acid receptor-β in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997; 89: 624-629. (Pubitemid 27200493)
37. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003; 94: 589-592. (Pubitemid 36975012)
38. Kikuchi S, Yamada D, Fukami T, Maruyama T, Ito A, Asamura H, et al . Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary non-small cell lung carcinoma. Cancer 2006; 106: 1751-1758.